Thus, regions containing known tumour suppressors on chromosome 9p, 17p and 18q were found homogenously, whereas amplifications targeting MYC, KRAS and GATA6—oncogenic events that drive metastatic progression and/or influence PDAC subtypes25,39,44—were heterogenous (Extended Data Fig. 11c–e). Here, KRAS is linked to neoplasm.